Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Cocrystal Pharma, Inc.'s (NASDAQ:COCP) management announces its participation in the upcoming Virtual Investor Summit Micro...
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(...
Cocrystal Pharma, Inc. (NASDAQ:COCP) ("Cocrystal" or the "Company") today reported favorable safety and tolerab...
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $10 pr...
HC Wainwright & Co. reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $10 price target.
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0....
